INTERCEPT: Identifying and Managing Cancer Treatment Cardiotoxicities in Patients Undergoing Therapy- Enduring

Learning Objectives

Review recent data on cytotoxic chemotherapies, targeted therapies, and immunotherapies known to cause cardiotoxicity in cancer patients

Discuss the use of clinical tools, imaging, and other tests to evaluate patients at risk for cardiotoxicity before, during, and after cancer treatment

Employ multidisciplinary strategies to mitigate the risk for cardiotoxicity in cancer patients.

Course summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)
Registration Opens: 
06/29/2021
Registration Expires: 
06/28/2023
Rating: 
0

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)
Please login or register to take this course.